No Data
No Data
Exact Sciences Is Maintained at Overweight by Piper Sandler
Watchmaker Genomics Advances TAPS Commercialization With Achievement of Key Technology Transfer Milestone
Piper Sandler Maintains Exact Sciences(EXAS.US) With Buy Rating, Cuts Target Price to $70
Express News | Exact Sciences Corp : Piper Sandler Cuts Target Price to $70 From $75
BTIG Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $65
BTIG Sticks to Its Buy Rating for Exact Sciences (EXAS)
Buy n Die Together❤ :
73610841 : Adrian Nathaniel carter, I can’t tag him and we’re Facebook friends, does anyone know why?
Seth Beaty : Though you know if you bet against Cathie Wood, you’ll probably make money.
Rob banks : is there an ETF for this ai medical sector?
Chak : is it goid time yo
get into TEM ?
View more comments...